Medical Insights from Industry

RSS
"Insights from Industry" is a dynamic series of interviews at the cutting edge of the medical industry. Every interviewee is a leader in their particular field and is handpicked to give an informative and accessible insight into their chosen field. These interviews are guaranteed to keep you in the know in a rapidly changing industry.
Non-surgical weight loss devices: an interview with Richard Thompson, CEO ReShape Medical

Non-surgical weight loss devices: an interview with Richard Thompson, CEO ReShape Medical

Non-invasive prenatal genetic screening: an interview with Dr. Charles Strom, Senior Medical Director, Quest Diagnostics

Non-invasive prenatal genetic screening: an interview with Dr. Charles Strom, Senior Medical Director, Quest Diagnostics

Anti-cancer drug conjugates: an interview with Dr Andreas Menrad, CSO Ablynx and Dr Chris Martin, CEO Spirogen

Anti-cancer drug conjugates: an interview with Dr Andreas Menrad, CSO Ablynx and Dr Chris Martin, CEO Spirogen

Microcystins in drinking water: an interview with Rohan Thakur, VP of Bruker CAM

Microcystins in drinking water: an interview with Rohan Thakur, VP of Bruker CAM

Medical adhesives for reusable or disposable medical devices: an interview with Robert Michaels, VP of Technical Sales, Master Bond

Medical adhesives for reusable or disposable medical devices: an interview with Robert Michaels, VP of Technical Sales, Master Bond

Breast cancer tests: an interview with Dr Steven Quay, CEO of Atossa Genetics

Breast cancer tests: an interview with Dr Steven Quay, CEO of Atossa Genetics

Antibody-drug conjugates (ADCs): an interview with Dr Marco Timmers, CSO at Synthon Biopharmaceuticals

Antibody-drug conjugates (ADCs): an interview with Dr Marco Timmers, CSO at Synthon Biopharmaceuticals

Otolaryngology, head and neck surgery: an interview with Thomas Cherry, Cook Medical

Otolaryngology, head and neck surgery: an interview with Thomas Cherry, Cook Medical

Metastatic renal cell carcinoma (mRCC) therapy: an interview with Charles A. Nicolette, Ph.D., CSO of Argos Therapeutics

Metastatic renal cell carcinoma (mRCC) therapy: an interview with Charles A. Nicolette, Ph.D., CSO of Argos Therapeutics

Bioluminescence microscopy: an interview with Robert Schmalzigaug, Olympus America

Bioluminescence microscopy: an interview with Robert Schmalzigaug, Olympus America

Finding medical applications for unused inventions: an interview with Gabriel Mecklenburg, Co-Founder of Marblar

Finding medical applications for unused inventions: an interview with Gabriel Mecklenburg, Co-Founder of Marblar

Neuromuscular blockade (NMB) reversal: an interview with Darryle Schoepp, senior vice president and head of Neuroscience and Ophthalmology, Merck Research Laboratories, Merck

Neuromuscular blockade (NMB) reversal: an interview with Darryle Schoepp, senior vice president and head of Neuroscience and Ophthalmology, Merck Research Laboratories, Merck

Macular pigment screening: an interview with Jaquie Finn, Product Line Manager at Elektron Technology

Macular pigment screening: an interview with Jaquie Finn, Product Line Manager at Elektron Technology

Dementia diagnosis: an interview with Dr Andrew Blackwell, Chief Scientific Officer, Cambridge Cognition

Dementia diagnosis: an interview with Dr Andrew Blackwell, Chief Scientific Officer, Cambridge Cognition

Regenerative medicine: an interview with Christophe Dardel, President of DSM Biomedical

Regenerative medicine: an interview with Christophe Dardel, President of DSM Biomedical

Sperm viability assessment: an interview with Caroline Feltham from Linkam Scientific Instruments

Sperm viability assessment: an interview with Caroline Feltham from Linkam Scientific Instruments

Exoskeleton technology: an interview with Larry Jasinski, CEO, ARGO Medical Technologies

Exoskeleton technology: an interview with Larry Jasinski, CEO, ARGO Medical Technologies

Cervical disc replacement: an interview with Joe Ross, VP of U.S. Marketing at LDR

Cervical disc replacement: an interview with Joe Ross, VP of U.S. Marketing at LDR

Nanoparticles and cancer treatment: an interview with John Stroh, CEO of Nanospectra Biosciences

Nanoparticles and cancer treatment: an interview with John Stroh, CEO of Nanospectra Biosciences

Fertility treatment auto-injector: an interview with Lai Chiu Tang, Senior Industrial Designer at Cambridge Consultants

Fertility treatment auto-injector: an interview with Lai Chiu Tang, Senior Industrial Designer at Cambridge Consultants